| | english | español | français |
Go to record ID

  Home|Finding Information|Record details   Printer-friendly version

Information Resource
Record information and status
Record ID
Date of creation
2007-09-02 12:51 UTC (UNEP-GEF)
Date of last update
2012-05-02 15:28 UTC (dina.abdelhakim@cbd.int)
Date of publication
2012-05-04 20:07 UTC (andrew.bowers@cbd.int)

General Information
Risk Assessment and Management of Genetically Modified Organisms under Australia's Gene Technology Act: Considerations for Regulatory Development
Nicholas A. Linacre; Jose Falck-Zepeda; John Komen; Donald MacLaren;
Organization(s) involved in the publication of this resource
Research and Information System for Developing Countries
  • English
Publication date
Summary, abstract or table of contents
This paper examines some of the potential regulatory issues that may be affecting the slow review process and approval of transgenic technologies in Australia as follows:  *A brief introduction to the regulatory structure in Australia is provided *The impacts of regional, national and state jurisdictions are considered *Cost-benefits analysis in decision making is discussed *The use of probabilistic risk assessments, based on mathematical models, in certain circumstances are discussed *Potential problems inherent in majority voting in a committee (i.e. group decision-making) are examined with recommendations
Thematic areas
Background material to the “Guidance on risk assessment of living modified organisms”
Is this document is recommend as background material for the “Guidance on Risk Assessment of Living Modified Organisms”
Section(s) of the “Guidance on Risk Assessment of Living Modified Organisms” this background material is relevant
Additional Information
Type of resource
  • Article (journal / magazine / newspaper)
¸ 2006, RIS. All rights reserved
Adobe Acrobat Reader (16 pages)
Asian Biotechnology and Development Review Vol. 8 No. 3, pp 1-16;
Keywords and any other relevant information
LMO categories: All LMO categories